Related by context. All words. (Click for frequent words.) 78 Vicinium TM 74 IRX 2 74 HuMax EGFr 74 ADVEXIN 73 mertansine 73 Annamycin 73 IMA# 73 recurrent refractory 73 Advexin 73 oral prodrug 72 metastatic colorectal 72 BRIM2 72 phase IIb clinical 72 Archexin 72 RhuDex ® 72 pertuzumab 72 depsipeptide 72 zalutumumab 72 recurrent squamous cell carcinoma 72 Alocrest 71 Panzem R NCD 71 Ceflatonin 71 IL# PE#QQR 71 Proxinium 71 Amrubicin 71 Aplidin 71 AEG# 71 OncoVEX GM CSF 71 ELACYT 71 anticancer compound 71 malignant ascites 71 Factor VIIa 71 Exherin TM 71 Sym# 71 huC# DM4 71 obatoclax 70 oral ridaforolimus 70 phase IIa clinical 70 Degarelix 70 docetaxel Taxotere R 70 Reolysin 70 luteinizing hormone releasing 70 Irinotecan 70 Panzem R 70 targeted radiotherapeutic 70 alvespimycin 70 IMC A# 70 MAGE A3 ASCI 70 Azedra 70 docetaxel Taxotere ® 70 Dacogen decitabine 70 romidepsin 70 BrachySil 70 PSMA ADC 70 CBLC# 70 recurrent metastatic 70 CEQ# 70 CA4P 70 ThermoDox R 70 CYT# potent vascular disrupting 70 Azedra TM 70 TheraCIM h R3 70 mapatumumab 70 receptor tyrosine kinase inhibitor 70 Cannabinor 70 YONDELIS 70 EFAPROXYN 70 investigational monoclonal antibody 69 GRN# 69 HuMax CD4 69 Zybrestat 69 JAK inhibitor 69 antibody MAb 69 LBH# 69 carboplatin paclitaxel 69 metastatic hormone refractory 69 Nexavar sorafenib 69 BAY #-# 69 sorafenib tablets 69 pegylated liposomal doxorubicin 69 relapsed leukemia 69 EOquin 69 biliary tract cancer 69 Vidaza azacitidine 69 Phase IIb clinical trials 69 bevacizumab Avastin ® 69 TELCYTA 69 EndoTAG TM -1 69 acyclovir Lauriad R 69 metastatic colorectal carcinoma 69 LHRH receptor positive 69 sodium thiosulfate STS 69 Aflibercept 69 chemoradiotherapy 69 CR# vcMMAE 69 Hepatocellular Carcinoma HCC 69 Fodosine 69 Clolar ® 69 INCB# [001] 69 Xanafide 69 PRT# 69 FOLOTYN ® 69 thalidomide Thalomid 69 Cetrorelix 69 Cloretazine R 69 Luteinizing Hormone Releasing Hormone 69 EOquin TM 69 SNT MC# 69 REOLYSIN ® 69 PNP inhibitor 69 Panzem 69 forodesine 69 Velcade bortezomib 69 baminercept 69 Erbitux cetuximab 69 NP2 Enkephalin 69 elacytarabine 69 OncoVEX 69 IV Busulfex 69 hormone LHRH antagonist 69 TBC# 69 Cellegesic 69 Cloretazine 69 DAVANAT 69 GW# [003] 68 Pirfenidone 68 XYOTAX TM 68 TheraCIM 68 cetuximab Erbitux ® 68 Safinamide 68 HQK 68 virus HCV protease inhibitor 68 humanised monoclonal antibody 68 BEMA TM Fentanyl 68 pharmacokinetic PK study 68 CD# monoclonal antibody 68 trastuzumab DM1 T DM1 68 SinuNase TM 68 ZACTIMA 68 elotuzumab 68 Pemetrexed 68 BrachySil ™ 68 Fibrillex TM 68 Amplimexon 68 metastatic malignant 68 volociximab 68 pain palliation 68 PDX pralatrexate 68 Virulizin ® 68 concurrent chemoradiation 68 Daclizumab 68 Epratuzumab 68 Quinamed 68 radiotherapeutic 68 Urocidin 68 TELINTRA 68 Tyrima 68 ThermoDox ® 68 TYZEKA 68 Personalized Immunotherapy 68 metaglidasen 68 pediatric acute lymphoblastic 68 relapsed refractory multiple myeloma 68 Atiprimod 68 Sudhir Agrawal D.Phil 68 goserelin 68 entinostat 68 Glufosfamide 68 Phase #b/#a clinical 68 delivers fluocinolone acetonide FA 68 refractory gout 68 histone deacetylase HDAC inhibitor 68 PrevOnco ™ 68 DXL# 68 vinca alkaloid 68 GEM OS1 68 vidofludimus 68 thymalfasin 68 Imprime PGG 68 Allovectin 7 68 oral deforolimus 68 BLP# Liposome Vaccine 68 Yondelis ® 68 Troxatyl 68 Omacetaxine 68 drug ISA# 68 BrachySil TM 68 Cloretazine ® 68 product Fentanyl TAIFUN 68 LymphoStat B belimumab 68 cell lymphoma CTCL 68 TACI Ig 68 Angiocept 68 Traficet EN 68 Onconase 68 anti EGFR antibody 68 acetonide FA 68 investigational humanized monoclonal antibody 68 Zorbtive TM 68 HGS ETR1 68 recurrent glioblastoma multiforme 68 PF # [002] 68 OMP #M# 68 MYDICAR ® 67 Zingo TM 67 OvaRex ® MAb 67 systemic anaplastic large 67 liposomal doxorubicin 67 Davanat 67 Xelox 67 Hycamtin 67 indibulin 67 Myocet 67 PEG SN# 67 HuLuc# 67 Vandetanib 67 personalized immunotherapy 67 Cx# [002] 67 GEM OS2 67 Pertuzumab 67 Phase Ib study 67 multiple myeloma MM 67 trastuzumab Herceptin R 67 Squalamine 67 Romidepsin 67 refractory chronic lymphocytic 67 OncoVex 67 BRAF inhibitor 67 randomized Phase IIb 67 investigational immunotherapy 67 Zenvia ™ 67 Taxotere docetaxel 67 Dacogen injection 67 lumiliximab 67 KNS # 67 Alpharadin 67 pan HDAC inhibitor 67 trastuzumab Herceptin 67 Iluvien ® 67 SCCHN 67 chimeric monoclonal antibody 67 Insegia 67 ACAPODENE 67 Nanobody 67 PKC# 67 Genasense ® 67 ADVEXIN p# therapy 67 PI3K/Akt pathway inhibitor 67 radiation sensitizer 67 Nexavar ® 67 dermaPACE TM 67 RAV# 67 liposomal formulation 67 Gliadel Wafer 67 GVAX ® 67 drug GAP #B# 67 sorafenib Nexavar 67 Cethrin R 67 SIR Spheres 67 tanespimycin 67 Zarnestra 67 gemcitabine Gemzar ® 67 metastatic bladder 67 Fibrin Pad 67 OHR/AVR# 67 neratinib 67 Tavocept 67 erlotinib Tarceva ® 67 pseudobulbar affect PBA 67 mitogen activated ERK kinase 67 ocular formulation 67 UPLYSO 67 Chemophase 67 Ambrisentan 67 multicenter Phase II 67 OPAXIO 67 carcinoma HCC 67 CD# antibody [001] 67 lenalidomide Revlimid R 67 TLK# 67 ZK EPO 67 Gemzar ® 67 eniluracil 67 proteasome inhibitor 67 ATL# [001] 67 ruxolitinib 67 Rituxan rituximab 67 gastrointestinal stromal tumors GIST 67 MGd 67 ZOLINZA 67 angiogenesis inhibitor 67 cetuximab Erbitux R 67 thetreatment 67 Aviptadil 67 Factor Xa inhibitor 67 therapeutic monoclonal antibody 67 Fludara 67 phase IIb trial 67 PANVAC VF 67 Afatinib 67 Enzastaurin 67 HER2 positive metastatic breast 67 Onco TCS 67 assessing T DM1 67 mRCC 67 recurrent glioblastoma 67 invasive candidiasis 67 cilengitide 67 Guanilib 67 Phase Ib clinical 67 dextromethorphan quinidine 67 Bezielle 67 occlusion PAO 67 kidney urologic 67 Gleevec imatinib mesylate 67 alkylating agent 67 YONDELIS R 67 mTOR inhibitor 67 Aplidin R 67 Mepact 67 HuMax CD# 67 vinorelbine tartrate 67 dasatinib Sprycel ® 67 alefacept 67 docetaxel Taxotere 67 Allovectin 7 ® 67 gefitinib Iressa 67 vorinostat 67 QuadraSphere 67 humanized monoclonal antibody 67 pralatrexate 67 Phase Ib II 67 AQ4N 67 relapsed multiple myeloma 67 PDE4 inhibitor 67 evaluating tivozanib 67 CCR9 antagonist 67 Icatibant 67 TEMODAL 67 TG# [003] 67 HepaSphere 67 etanercept Enbrel 67 rALLy clinical trial 67 Campath alemtuzumab 67 Gleevec resistant 67 Marqibo TM 67 PrevOnco 67 R sorafenib tablets 67 paclitaxel poliglumex 67 IMC #B 66 Dapagliflozin 66 Removab 66 Carfilzomib 66 adjuvant colon cancer 66 cutaneous T cell 66 CCX# 66 Genasense ® oblimersen 66 MabCampath 66 PEGylated interferon 66 farletuzumab 66 HGS ETR2 66 refractory prostate cancer 66 Panzem NCD 66 motexafin gadolinium Injection 66 ospemifene 66 pancreatic gastric 66 Tarvacin TM 66 Alfimeprase 66 Clavis Pharma 66 Uvidem 66 Trabectedin 66 cediranib 66 Solazed 66 chemotherapy induced neutropenia 66 papillary renal cell carcinoma 66 Cotara R 66 Xeloda ® 66 OvaRex R 66 immunotherapeutic agent 66 metastatic malignant melanoma 66 MyVax R 66 Ocrelizumab 66 RH1 66 lapatinib Tykerb 66 Zalypsis 66 PhG alpha 1 66 MGCD# [001] 66 MEK inhibitors 66 paclitaxel Taxol R 66 Proellex TM 66 lomitapide 66 octreotide implant 66 opioid induced bowel dysfunction 66 drug conjugate 66 ixabepilone 66 SinuNase ™ 66 methylnaltrexone 66 talactoferrin 66 bortezomib Velcade 66 MOZOBIL 66 CIMZIA TM 66 NXL# 66 reslizumab 66 TRO# 66 Cloretazine R VNP#M 66 dextofisopam 66 orBec 66 Resten NG 66 Bortezomib 66 TOCOSOL Camptothecin 66 ATL/TV# 66 CB2 selective receptor agonist 66 Telatinib 66 Seliciclib 66 somatostatin analogue 66 trastuzumab DM1 66 Specifid 66 Phase Ib clinical trials 66 trial evaluating PRX# 66 Viventia 66 Silodosin 66 superficial bladder cancer 66 tiapamil 66 cancer immunotherapies 66 Mipomersen 66 Androxal TM 66 TNFerade TM 66 Abiraterone acetate 66 castrate resistant prostate cancer 66 ara C 66 fluoropyrimidine 66 talabostat 66 GRNVAC1 66 Catena ® 66 HSP# inhibitor 66 relapsed ovarian cancer 66 metastatic carcinoma 66 TKM ApoB 66 epithelial tumors 66 LHRH antagonist 66 histone deacetylase inhibitor 66 including eniluracil ADH 66 HspE7 66 OMP #R# 66 Kepivance 66 Phase 1b clinical trials 66 investigational HCV polymerase 66 huN# DM1 66 Ixempra 66 inhibitor RG# 66 LymphoStat B TM 66 familial amyloidotic polyneuropathy FAP 66 investigational therapies 66 castration resistant prostate cancer 66 zanolimumab 66 Solazed TM 66 OncoGel 66 Ridaforolimus 66 amrubicin 66 Elotuzumab 66 IAP inhibitors 66 Microplasmin 66 Virulizin R 66 immatics 66 allogeneic cell 66 palliative radiotherapy 66 Fludara ® 66 targeted antifolate 66 Junovan 66 Apaziquone 66 MEK inhibitor 66 prostate cancer CRPC 66 Phase #/#a trial 66 chemotherapy cisplatin 66 humanized antibody 66 Onalta 66 Capesaris 66 PRX# 66 Soliris TM eculizumab 66 IAP inhibitor 66 ENMD # 66 methylnaltrexone bromide 66 Etoposide 66 fosbretabulin 66 seliciclib CYC# 66 Zemiva TM 66 Aurexis 66 gemcitabine Gemzar 66 PEG interferon 66 axitinib 66 dalbavancin 66 PD LID 66 VNP#M 66 Mitomycin C 66 intravesical infusion therapy 66 ALN TTR# 66 Eculizumab 66 chemoradiation therapy 66 Onalta ™ 66 Cotara ® 65 Folotyn 65 Campath ® 65 Triapine R 65 Cloretazine VNP#M 65 BCG refractory carcinoma 65 metastatic gastric 65 adecatumumab 65 Fx #A 65 CYC# 65 Evoltra ® 65 recurrent NSCLC 65 DEB# 65 Neuradiab 65 oncolytic virus therapy 65 generation purine nucleoside 65 Peginterferon alfa 2b 65 humanized anti 65 picoplatin 65 Gefitinib 65 sunitinib malate 65 rNAPc2 65 noninfectious uveitis 65 AA amyloidosis 65 BZL# 65 nonsmall cell lung cancer 65 Temsirolimus 65 JAK2 inhibitor 65 INCB# [003] 65 oncolytic vaccine 65 IgG1 monoclonal antibody 65 Nimotuzumab 65 personalized cellular immunotherapy 65 registrational trial 65 TG# [001] 65 OZURDEX ® 65 refractory AML 65 metastatic castrate resistant 65 diarrhea predominant irritable 65 polysaccharide polymer 65 tramiprosate Alzhemed TM 65 vascular disrupting agents 65 PROVENGE sipuleucel T 65 Aloxi injection 65 VitiGam 65 HuMax TAC 65 CD3 monoclonal antibody 65 candidate TNFerade biologic 65 PGL# 65 relapsing multiple sclerosis 65 multi kinase inhibitor 65 TASQ 65 Tarceva TM 65 AAG geldanamycin analog 65 vascular disrupting agent 65 Pradefovir 65 KRN# 65 LEUKINE 65 BioNumerik 65 TNF Tumor Necrosis Factor 65 Ceflatonin R 65 oropharyngeal candidiasis 65 nucleoside analog 65 bardoxolone methyl 65 Li Fraumeni Syndrome 65 plasma kallikrein inhibitor 65 CINQUIL 65 cetuximab Erbitux 65 Phase IIa trial 65 Deforolimus 65 Pyridorin 65 RCW breast cancer 65 Radiation Therapy SIRT 65 DU #b 65 beta 1a 65 anticancer agent 65 Xcytrin R 65 Cethrin 65 TH# [003] 65 BEMA TM LA 65 novel therapeutic antibodies 65 Navelbine ® 65 TORISEL 65 hormone agonist 65 metastatic renal cell carcinoma 65 Protexia R 65 Herceptin trastuzumab 65 XmAb# 65 brivaracetam 65 Veronate 65 standard chemotherapy regimen 65 bortezomib Velcade R 65 antiangiogenic therapy 65 Evoltra 65 AzaSite Plus 65 L BLP# 65 ADVEXIN therapy 65 ularitide 65 monoclonal anti 65 JAK1 65 miconazole Lauriad ® 65 Amigal 65 EndoTAGTM 1 65 oncolytic virotherapy 65 histamine dihydrochloride 65 cangrelor 65 chemotherapeutic drug 65 Diabetic Macular Edema DME 65 5 fluorouracil leucovorin 65 autologous cellular immunotherapy 65 Taxotere ® 65 vemurafenib 65 trastuzumab Herceptin ® 65 MNTX 65 FOLFOX6 65 RhuDex R 65 TroVax ® 65 G#DT 65 SUTENT 65 ATL# [002] 65 PEGylated Fab fragment 65 Chrysalin 65 rituximab Rituxan 65 sitaxsentan 65 velafermin 65 trabectedin 65 Vitaxin 65 Ozarelix 65 platinum refractory 65 Combination REOLYSIN R 65 Tarvacin 65 PEP# [003] 65 Cetuximab Erbitux 65 midstage clinical trials 65 Pivotal Phase III 65 phase IIb study 65 isoform selective 65 Augment TM 65 ALGRX 65 Alzhemed TM 65 deforolimus 65 antimetabolite 65 metastatic androgen independent 65 pancreatic colon 65 omacetaxine mepesuccinate 65 leukemia AML 65 Desmoteplase 65 Phase #b/#a 65 benign prostatic hypertrophy BPH 65 oral antiviral 65 gemcitabine chemotherapy 65 anti angiogenic agent 65 EndoTAG 65 Pimavanserin 65 LEP ETU 65 VALSTAR TM 65 Curaxin CBLC# 65 R#/MEM # 65 IMiDs ® compound 65 Ontak 65 IMiDs R 65 ILUVIEN ® 65 torezolid phosphate 65 mifamurtide 65 Abbokinase 65 Dasatinib 65 A3 adenosine receptor 65 MEK inhibitor RDEA# 65 M2 subunit 65 CIMZIA ™ 65 bevacizumab Avastin 65 DCVax ® Brain 65 Generx ™ 65 luliconazole 65 PEGylated anti 65 Zolinza 65 regorafenib 65 Raptiva R 65 isavuconazole 65 azacytidine 65 Olaparib 65 potent antiproliferative 65 SUCCEED trial 65 lexidronam injection 65 Urocidin TM 65 dirucotide 65 EXPAREL TM 65 microtubule inhibitor 65 Chemokine Therapeutics 65 orally administered inhibitor 65 TRAIL receptor antibodies 65 tesmilifene 65 GED aPC 65 cannabinor 65 prostate cancer HRPC 65 Sapacitabine 65 preclinically 65 dacetuzumab 65 enzastaurin 65 combretastatin A4 phosphate CA4P 65 rhThrombin 65 Nanobody ® 65 ganetespib 65 alvimopan 65 IgG1 antibody 65 Bazedoxifene 65 #D#C# 65 VA# [002] 65 CTAP# Capsules 65 anti angiogenic agents 65 severe oral mucositis 65 humanised antibody 65 Tarceva erlotinib 65 ZFP TF 65 Cancidas 65 SUTENT ® 65 rindopepimut 65 pancreatic adenocarcinoma 65 metastatic GIST 65 hormone refractory metastatic prostate 65 adalimumab Humira 65 PREOS 65 p# biomarker 65 VAPRISOL 65 Neupogen ® 65 AVASTIN 65 PXD# 65 Tesetaxel 65 intravesical instillation 65 PI3K inhibitor 65 PARP inhibitor 65 Neuvenge 65 Evoltra TM 65 FK# 65 investigational antiplatelet agent 65 FUSILEV ® 65 vaccines oncolytic virus 65 HRPC 65 omega interferon 65 SPRYCEL ® 65 DCVax R 65 Tanespimycin 65 decitabine 65 Combidex 65 Loramyc R 65 HyACT 65 essential thrombocythemia ET 65 Golimumab 65 CHOP chemotherapy 65 antisense inhibitors 65 tafamidis 65 R Saizen R 65 2 methoxyestradiol 65 targeting CD# 64 WX UK1 64 acyclovir Lauriad ® 64 lintuzumab 64 metastatic CRC 64 RhuDex TM 64 Trastuzumab 64 Aptivus ® 64 MKC# MKC# PP 64 Gelclair 64 Selective Internal 64 ISF# 64 Soliris eculizumab 64 glufosfamide 64 Mycograb 64 Doxil ® 64 galiximab 64 Pazopanib 64 docetaxel chemotherapy 64 PROCHYMAL 64 relapsing remitting MS RRMS 64 Tykerb lapatinib 64 ToGA 64 daptomycin 64 ONCASPAR 64 Augment Injectable 64 Cleviprex TM clevidipine 64 ONCONASE R 64 Octreotide 64 metastatic HRPC 64 HGS# 64 pegfilgrastim 64 zoledronic acid Zometa 64 preclinical efficacy 64 ProSavin 64 palifermin 64 Copegus ribavirin 64 immunotherapeutic vaccine 64 Genentech Rituxan 64 cleavable linker 64 acadesine 64 metastatic pancreatic 64 Besivance 64 compound perifosine 64 oblimersen 64 EP #R 64 Phase #b/#a trial 64 alfa 2a 64 DPX Survivac 64 Phase IIIb clinical 64 xanthine oxidase inhibitor 64 #I TM# 64 INCB# [002] 64 intranasal formulation 64 Excellagen 64 urethral bulking agent 64 ocrelizumab 64 Gemcitabine 64 riociguat 64 RLY# 64 Sutent sunitinib 64 oral talactoferrin 64 corticosteroid dexamethasone 64 Leukine ® 64 rhITF 64 Marqibo 64 budesonide foam 64 Phase IIb trials 64 canakinumab 64 Friedreich Ataxia FRDA 64 GLP toxicology studies 64 afamelanotide 64 CRD5 64 selective androgen receptor modulator 64 Theratope 64 BNC# 64 anti CD3 64 Azixa 64 Cardio Vascu Grow 64 Solazed ™ 64 BENLYSTA ® 64 protein kinase inhibitor 64 Firazyr 64 TLR9 agonist 64 PNT# 64 Bendamustine 64 sodium Injection 64 pomalidomide 64 CRLX# 64 Perifosine 64 Intravenous CP 64 opioid induced constipation OIC 64 VIR# 64 eltrombopag 64 antibody MT# 64 Neulasta ® 64 LibiGel ® 64 denileukin diftitox 64 molecular imaging radiopharmaceutical 64 StemEx R 64 Camptosar ® 64 Tezampanel 64 untreated metastatic melanoma 64 recurrent malignant glioma 64 refractory metastatic colorectal cancer 64 Viramidine 64 idarubicin 64 NP2 64 comparator arm 64 Ophena 64 oncolytic virus therapies 64 Diamyd ® 64 Familial Adenomatous Polyposis FAP 64 DCVax Brain 64 peritumoral brain edema 64 locoregional disease 64 aflibercept VEGF Trap 64 Myelodysplastic Syndrome MDS 64 non resectable metastatic 64 paclitaxel Taxol ® 64 Kit CD# positive 64 refractory multiple myeloma 64 Raptiva ® 64 Torisel 64 immunological diseases 64 KSP inhibitor 64 ozarelix 64 taxane chemotherapy 64 DAPT 64 cell carcinoma RCC 64 herpetic keratitis 64 Angiolix 64 Combo Stent 64 refractory metastatic 64 apaziquone 64 antiproliferative effects 64 Surgical resection 64 CytoFab ™ 64 ongoing Phase 1b 64 stage IIIB 64 Phase 2b clinical trials 64 CD# CEA 64 E1 INT TM 64 PSN# [002] 64 HCV protease inhibitor 64 custirsen 64 Talabostat 64 dasatinib Sprycel 64 phase IIb 64 TNFerade 64 catheter occlusion 64 Ostabolin C 64 gastrointestinal stromal tumors 64 ThGRF 64 TYSABRI natalizumab 64 Cimzia certolizumab pegol 64 unresectable stage 64 modified glutathione analog 64 selective adenosine 64 Rituximab 64 acute peripheral arterial 64 Epidermal Growth Factor Receptor 64 Lixivaptan 64 ulimorelin 64 metastatic carcinoid 64 nalbuphine ER 64 intravenous acetaminophen 64 PHX# 64 Pralatrexate 64 DOXIL 64 ZEVALIN ® 64 bleomycin 64 biologic therapy 64 GALNS 64 anti inflammatory NSAID 64 Vidaza ® 64 T DM1 64 Neulasta R 64 Iluvien TM 64 micafungin 64 teduglutide 64 bardoxolone 64 ASONEP 64 tramiprosate 64 oxypurinol 64 Glypromate 64 Onalta TM 64 diabetic neuropathic pain 64 PLK1 SNALP 64 Tumour Vascular Disrupting Agent 64 oral anticancer 64 paclitaxel Taxol 64 PROSTVAC TM 64 Novolimus 64 L Annamycin 64 Interferon beta 64 TASKi3 64 refractory colorectal cancer 64 Targretin 64 investigational pharmacologically unique 64 Rilonacept 64 topically applied SEPA 64 ribavirin RBV 64 Voreloxin 64 pentostatin 64 nab paclitaxel 64 Tovaxin TM 64 Initiate Clinical Trial 64 Microspheres 64 Lilly Gemzar 64 prostate cancer antigen prostatic 64 vapreotide acetate 64 ofatumumab HuMax CD# 64 Ketotransdel 64 EGFR inhibitors 64 Advanced Renal Cell 64 PEGylated 64 Vascular Wrap 64 Aurora kinase 64 skeletal metastases 64 Platinol 64 novel VDA molecule 64 Modrenal R 64 Lenalidomide 64 recurrent herpes labialis 64 Sanvar R 64 unresectable tumors 64 Dupuytren Contracture 64 BiovaxID TM 64 refractory cutaneous T 64 PREOS R 64 CRMD# 64 Xeloda capecitabine 64 PTH analogue 64 Lubiprostone 64 OvaRex 64 JAK3 64 OMS#HP 64 TheraSphere 64 TAXOTERE ® 64 ASA# 64 compound AEZS 64 Atrasentan 64 Zyclara 64 neoadjuvant therapy 64 ACTEMRA TM 64 ATPace TM